Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$571K Sell
1,823
-127
-7% -$37.6K 0.06% 124
2017
Q2
$529K Buy
1,950
+157
+9% +$41.5K 0.05% 118
2017
Q1
$490K Buy
1,793
+344
+24% +$97.3K 0.05% 124
2016
Q4
$411K Buy
1,449
+53
+4% +$15.7K 0.05% 130
2016
Q3
$437K Buy
1,396
+104
+8% +$30.8K 0.05% 136
2016
Q2
$312K Sell
1,292
-40
-3% -$10.5K 0.03% 155
2016
Q1
$347K Buy
+1,332
New +$352K 0.04% 146

Other funds holding BIIB

BancorpSouth's BIIB Position: Q3 2017 in Review

BancorpSouth reduced its Biogen (BIIB) stake by 6.5% in Q3 2017, selling an estimated $37.6K and leaving 1,823 shares worth $571K. The position accounts for 0.06% of the portfolio, ranked #124.

BancorpSouth first reported a position in BIIB in Q1 2016 and has held it in 7 quarters since. 1,014 funds tracked by Wall St. Rank hold BIIB as of Q3 2017.

  • BancorpSouth held 1,823 shares of Biogen worth $571K as of Q3 2017.
  • BancorpSouth sold 127 Biogen shares in Q3 2017, an estimated $37.6K.
  • Biogen made up 0.06% of BancorpSouth's portfolio in Q3 2017, its #124 holding.
  • BancorpSouth first reported a position in Biogen in Q1 2016 and has held it in 7 quarters since.
  • 1,014 funds tracked by Wall St. Rank held Biogen as of Q3 2017.

Based on BancorpSouth's 13F filing for Q3 2017, filed 14 Nov 2017.